Gorav Ravi MD is categorized under Ear Nose and Throat Doctors in Las Cruces, NM and active since 2005.
Gorav Ravi MD was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Ear Nose and Throat Doctors business, which does work in the B2C market, and is classified as a Ear Nose and Throat Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ravi Gorav at the company’s single location by writing to 2540 South Telshor Boulevard, Las Cruces, New Mexico NM 88011 or by phoning (575) 522-7982. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Gorav Ravi MD |
Contact Person: | Ravi Gorav |
Address: | 2540 South Telshor Boulevard, Las Cruces, New Mexico 88011 |
Phone Number: | (575) 522-7982 |
Website Address: | lascrucesfacialplastic.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Ear Nose and Throat Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Gorav Ravi MD was started in 2005 to provide professional Ear Nose and Throat Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ravi Gorav for inquiries that concern Gorav Ravi MD by calling the company number (575) 522-7982, as your correspondence is most welcome. Additionally, the physical location of the single location of Gorav Ravi MD can be found at the coordinates 32.29145,-106.73493 as well as the street address 2540 South Telshor Boulevard in Las Cruces, New Mexico 88011.
For its online presence, you may visit Gorav Ravi MD’s website at lascrucesfacialplastic.com and engage with its social media outlets through on Twitter and on Facebook.